As part of "heart health month," we're looking at lipoprotein (a). For decades, doctors have encouraged patients to monitor their cholesterol levels, with studies showing that heart disease risk ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

Please provide your email address to receive an email when new articles are posted on . This installment of Pipeline Pulse focuses on a single cardiovascular risk ...

When considering risk factors for heart attacks and strokes, most people think of the usual players: LDL cholesterol (think L for lousy, or “bad”), HDL cholesterol (think H for healthy, or “good”), ...

HealthDay News — Testing for lipoprotein (a) (Lp [a]) increased from 2015 to 2024, but is still low, according to a study published online Sept. 26 in JACC: Advances.

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. CHICAGO — Lipoprotein(a) is a risk factor for ...

In a recent study published in the journal Current Medical Research and Opinion, researchers report that high lipoprotein(a) levels were linked to repeated coronary heart disease events in older ...

A recent study published in the Virology Journal has highlighted the significance of high-density lipoprotein (HDL) in coronavirus disease 2019 (COVID-19) pathogenesis and outcome. A severely low ...

Following these positive 36-week results, Silence Therapeutics plans to announce 48-week results of the ongoing ALPACAR-360 study in Q2 of 2024. Silence Therapeutics has released promising findings ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepatic ...